Related Experiment Videos
Potential role of the epidermal growth factor receptor in human pancreatic cancer
1Department of Medicine, University of California, Irvine 92717.
Abstract:
The epidermal growth factor (EGF) receptor is a transmembrane protein that has tyrosine kinase activity. It is activated by both EGF and transforming growth factor-alpha (TGF-alpha). Human pancreatic cancer cells overexpress the EGF receptor and exhibit a parallel increase in EGF receptor mRNA without a detectable increase in the number of gene copies coding for the receptor. These cells also produce TGF-alpha and are capable of binding exogenous TGF-alpha. They often recycle EGF, but markedly and rapidly degrade TGF-alpha. However, TGF-alpha is 10-100-fold more potent than EGF in enhancing their anchorage-independent growth. Both growth factors induce EGF receptor down-regulation, but EGF is more efficient than TGF-alpha in this regard. The concomitant overexpression of the EGF receptor and production of TGF-alpha, the recycling of EGF, and the attenuated ability of TGF-alpha to down-regulate the EGF receptor may combine to provide a distinct growth advantage to human pancreatic cancer cells.
Insights
Human pancreatic cancer cells overexpress the epidermal growth factor (EGF) receptor and produce TGF-alpha. This, along with altered growth factor degradation and recycling, may confer a growth advantage.
Area of Science:
- Molecular Biology
- Oncology
- Cell Signaling
Background:
- The epidermal growth factor (EGF) receptor is a key transmembrane protein with tyrosine kinase activity.
- EGF receptor signaling is implicated in various cancers, including pancreatic cancer.
Purpose of the Study:
- To investigate the role of EGF receptor and its ligands, EGF and TGF-alpha, in human pancreatic cancer cell growth.
- To elucidate the mechanisms of growth factor interaction and signaling in pancreatic cancer.
Main Methods:
- Analysis of EGF receptor mRNA and gene copy number in pancreatic cancer cells.
- Assessment of TGF-alpha production, binding, and degradation.
- Evaluation of EGF and TGF-alpha effects on anchorage-independent growth and receptor down-regulation.
Main Results:
- Human pancreatic cancer cells overexpress EGF receptor mRNA without gene amplification.
- These cells produce TGF-alpha, bind exogenous TGF-alpha, and degrade TGF-alpha more rapidly than EGF.
- TGF-alpha is significantly more potent than EGF in promoting anchorage-independent growth, despite EGF being more effective at receptor down-regulation.
Conclusions:
- The combined overexpression of EGF receptor, TGF-alpha production, altered growth factor degradation/recycling, and differential receptor down-regulation provides a distinct growth advantage to human pancreatic cancer cells.
- Targeting EGF receptor signaling pathways may offer therapeutic strategies for pancreatic cancer.